EUVIMED · CrossrefJournal
The Oncologist
ISSN 1083-7159 · Oxford University Press (OUP)
Latest articles
Revisiting the Role of Mouse Mammary Tumor Virus (MMTV) in Breast Cancer Through the Lens of a Signal Peptide
Prognostic Factors for Survival in ICI-Treated NSCLC: An Umbrella Review of Evidence Certainty and Clinical Relevance
Blood Cell Count Ratios Predict Immune-related Adverse Events in Metastatic Renal Cell Carcinoma Treated With First-Line Immune Checkpoint Inhibitors
Ocular comorbidities are common in multiple myeloma: results of a large cross-sectional survey
Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas
RWE: what is its regulatory fate?
Real-World LAG3 Expression as A Biomarker in Advanced Melanoma: Implications for Treatment Selection
Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer
A prospective trial of a personalized exercise program in patients with advanced prostate cancer
Treatment Hotspots and Controversies in Papillary Thyroid Microcarcinoma
Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinations
National Gaps in Appendiceal Cancer Care and Implementation of a Regional Virtual Multidisciplinary Care Conference
TAVO412, an Anti-EGFR, cMET and VEGF Trispecific Antibody: Initial Results from a Phase I Dose Escalation Study in Patients with Advanced Solid Tumors
Tumor Longevity: a time-dependent biomarker of immune checkpoint inhibitor responsiveness across head and neck, lung, renal and urothelial cancers
A phase 2 study of tipifarnib in children and young adults with tumors harboring HRAS genomic alterations: NCI-COG Pediatric MATCH trial (APEC1621M)
Reference frame for adult brainstem gliomas
Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
Characteristics and outcomes of NATALEE- and monarchE-eligible early breast cancer in Finland: a regional real-world cohort study
Site-specific outcomes and genomics in metastatic pancreatic ductal adenocarcinoma
Targeting the MTAP-PRMT5 axis: from synthetic lethality to emerging therapeutic opportunities
Sequential therapy with anlotinib and radioiodine for distant metastatic differentiated thyroid cancer: a phase II clinical trial
Pelvic insufficiency fractures after chemoradiotherapy for cervical cancer: incidence, long-term outcomes, and survivorship management
A novel referral system to optimize timing to specialized palliative care in patients with advanced cancer: an interventional study
Gabapentinoids for oncologic pruritus: a retrospective cohort study
Rethinking radiation therapy in the era of RAS inhibition for pancreatic cancer
Real-world treatment patterns and survival outcomes in extensive-stage small cell lung cancer across first-line induction and maintenance therapy
Immunotherapy and cancer: the CIPOMO viewpoint on challenges and opportunities
Behind every subject line
Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study
Peri-treatment Creatinine-Based eGFR Trajectories in Patients Receiving Breast Radiotherapy: A Retrospective Cohort Study
Volumes
2026 · 6552025 · 6742024 · 4062023 · 3272022 · 2862021 · 4652020 · 4482019 · 4152018 · 2592017 · 2392016 · 2342015 · 2602014 · 2162013 · 2492012 · 2542011 · 2552010 · 2082009 · 1752008 · 1952007 · 1902006 · 1582005 · 1392004 · 1292003 · 1152002 · 1622001 · 1512000 · 1151999 · 691998 · 681997 · 861996 · 70
EUVIMED